biostudies-literatureHahn EAIntramural NIH HHSNCI NIH HHS149-161https://www.ebi.ac.uk/biostudies/studies/S-EPMC11329347biostudies-literatureUnknown120(1)<h4>Purpose</h4>Our purpose was to evaluate the measurement properties of patient-reported outcome (PRO) measures used in the ongoing RadComp pragmatic randomized clinical trial (PRCT).<h4>Methods and materials</h4>The deidentified and blinded data set included 774 English-speaking female participants who completed their 6-month posttreatment assessment. Eleven PRO measures were evaluated, including the Trial Outcome Index from the Functional Assessment of Cancer Therapy-Breast (FACT-B), Satisfaction with Breast Cosmetic Outcomes, the BREAST-Q, and selected Patient-Reported Outcomes Measurement Information System (PROMIS) measures. PROs were measured at 3 timepoints: baseline, completion of radiation therapy (RT), and 6 months post-RT. Ten variables were used as validity anchors. Pearson oInternational journal of radiation oncology, biology, physicsValidation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp Trial.PMC11329347P30 CA008748K08 CA252640Z99 CA999999Taghian AGChen PYAlgan ODover LSiegal AMStephenson LWilloughby TRomesser PBKy BCroog VJPatel SSturgeon JDHalyard MYHamstra DALin LLPrior FKatz SMedek SAHong JJNovick KLDeBlois DMcCormick BBradley JAMah DHaffty BGWeksberg DCMacDonald SMLockney NLin HManke HKunaprayoon DKCorbin KSYu JJoyner MMHahn EAParikh DMcAvoy SASmith BDKang KHManu MysoreHencek CBraunstein LZHong LBhooshan NWong TFagundes MVyfhuis MALBerman ATDriscoll APaganetti HPowell SNGewanter RMYu ANarezkina AMitchell SAVela AMZielan RRDong LBennouna JBaas CCroley RKonski AAChen YBekelman JEMcDonald ARemmes NBLi HHyde COhri NChen KWilcox NRutenberg MChen CCMueller BAMihalcik SAWright JLDvorak TLu HLGilbo PSeibert TPhreaner NPaulus RJackson AAkthar ASBalanescu DMychalczak BZou WUrbanic JJMajithia LPanoff JMayadev JSLaPlant QMcGee LAYue NJPatel ANFeriozzi ADepauw NAkhter NLiang XZoberi IWilson JJagsi RGuttman DMZeidan OBenhabib SGodishala APang DMailhot RBLyons JRao ADMoiseenko VCella DWalker AJCardan RABernstein MKolker JDHarris EEMeier TDonisan TVallabhaneni SBakhoum SFFreedman GMGelblum DYTabakha SBosch WStutz MDWilkinson JBDalton ALee CCheng RCuaron JJBoggs DHChen ETMitchell JGodette KDHenson CEPoenisch FDaugherty ECMann JRash DShumway DASuero-Abreu GStinson STaunk NKKesslering CMDadkhah HMishra MVWang CJStrom EAPugh SLBarron DAAhmad NWang PRosen LRGoyal SHoffman KECahlon OParhar PKRudra SYan ESKim JNGillespie EFTerry WuHo AAmelia Rodrigues MThukral ADPankuch MSoto DFeigenberg SJYashar CJimenez RBDevisetty KStudy Group Investigators:Shepherd AFMendenhall NRoth O'Brien DPafundi DHZinovoy MNichols EMDaniella Dang PDing XMutter RWXu ADilworth JTStraube WReza NMitchell MPKim HKChoi JIMascia AWang WAKhan ANowak Choi KAChawla ASmith KTsai HKFang LCSchupak KDLangen KMfalseValidation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp Trial.<h4>Purpose</h4>Our purpose was to evaluate the measurement properties of patient-reported outcome (PRO) measures used in the ongoing RadComp pragmatic randomized clinical trial (PRCT).<h4>Methods and materials</h4>The deidentified and blinded data set included 774 English-speaking female participants who completed their 6-month posttreatment assessment. Eleven PRO measures were evaluated, including the Trial Outcome Index from the Functional Assessment of Cancer Therapy-Breast (FACT-B), Satisfaction with Breast Cosmetic Outcomes, the BREAST-Q, and selected Patient-Reported Outcomes Measurement Information System (PROMIS) measures. PROs were measured at 3 timepoints: baseline, completion of radiation therapy (RT), and 6 months post-RT. Ten variables were used as validity anchors. Pearson o2024-01-01T00:00:00Z2024 Sep2026-06-02T09:13:06.615Z2024-11-09T11:00:27.959ZS-EPMC113293473873904710.1016/j.ijrobp.2024.03.020